SIT INVESTMENT ASSOCIATES INC - BAXTER INTL INC ownership

BAXTER INTL INC's ticker is BAX and the CUSIP is 071813109. A total of 1,096 filers reported holding BAXTER INTL INC in Q4 2020. The put-call ratio across all filers is 0.87 and the average weighting 0.2%.

About BAXTER INTL INC

Baxter International Inc. is a global healthcare company that specializes in developing and manufacturing medical products and therapies. The company has a long history of innovation and has been at the forefront of developing life-saving treatments for patients around the world.

Baxter's product portfolio includes a wide range of medical devices, pharmaceuticals, and biotechnology products. The company's products are used in hospitals, clinics, and other healthcare settings to treat a variety of conditions, including hemophilia, immune disorders, kidney disease, and other chronic and acute medical conditions.

Baxter's commitment to innovation has helped the company maintain a strong position in the healthcare industry. The company invests heavily in research and development, and has a strong pipeline of new products in development.

Baxter's leadership team is also a key strength of the company. The CEO, José Almeida, has a strong track record of success in the healthcare industry, and has been instrumental in driving the company's growth and success.

Overall, Baxter International Inc. is a strong and innovative company that is well-positioned to continue delivering value to patients, healthcare providers, and investors alike. With a strong product portfolio, a commitment to innovation, and a talented leadership team, Baxter is a company that investors should keep an eye on in the years to come.

It's important to note that this information is for educational purposes only and has not been fact-checked. As with any investment, it's important to do your own research and consult with a financial advisor before making any investment decisions.

Quarter-by-quarter ownership
SIT INVESTMENT ASSOCIATES INC ownership history of BAXTER INTL INC
ValueSharesWeighting
Q4 2022$166
-100.0%
3,265
-97.6%
0.01%
-97.7%
Q3 2022$7,213,000
-48.8%
133,925
-38.9%
0.22%
-49.5%
Q2 2022$14,076,000
-33.2%
219,155
-19.3%
0.43%
-24.5%
Q1 2022$21,061,000
-0.0%
271,620
+10.7%
0.57%
+14.5%
Q4 2021$21,063,000
+66.1%
245,375
+55.6%
0.50%
+50.9%
Q3 2021$12,683,000
+5055.7%
157,690
+5070.2%
0.33%
+5366.7%
Q2 2021$246,000
-4.3%
3,0500.0%0.01%
-14.3%
Q1 2021$257,000
+43.6%
3,050
+37.1%
0.01%
+40.0%
Q4 2020$179,000
-98.4%
2,225
-98.3%
0.01%
-97.1%
Q3 2020$11,328,000
+15417.8%
129,575
+15144.1%
0.17%
+8400.0%
Q2 2020$73,000
+5.8%
8500.0%0.00%
-33.3%
Q1 2020$69,000
-98.7%
850
-98.7%
0.00%
-98.1%
Q4 2019$5,412,000
-51.9%
64,725
-49.7%
0.15%
-55.5%
Q3 2019$11,260,000
+3.9%
128,725
-2.7%
0.35%
+3.6%
Q2 2019$10,835,000
-1.2%
132,300
-1.9%
0.33%
-3.7%
Q1 2019$10,969,000
-2.4%
134,900
-21.0%
0.35%
-4.1%
Q4 2018$11,240,000
-41.0%
170,775
-30.9%
0.36%
-25.8%
Q3 2018$19,045,000
+68.5%
247,050
+61.4%
0.49%
+67.7%
Q2 2018$11,303,000
+20450.9%
153,075
+17908.8%
0.29%
+29000.0%
Q1 2018$55,0000.0%8500.0%0.00%0.0%
Q4 2017$55,000
-14.1%
850
-16.6%
0.00%
-50.0%
Q3 2017$64,000
+540.0%
1,019
+503.0%
0.00%
Q2 2017$10,000
+11.1%
1690.0%0.00%
Q1 2017$9,000
+28.6%
1690.0%0.00%
Q4 2016$7,000
-100.0%
169
-100.0%
0.00%
-100.0%
Q4 2013$26,829,000
-44.1%
385,745
-44.4%
0.48%
-50.9%
Q2 2013$48,023,000693,2700.97%
Other shareholders
BAXTER INTL INC shareholders Q4 2020
NameSharesValueWeighting ↓
JONES ROAD CAPITAL MANAGEMENT, L.P. 200,000$7,548,0006.60%
BOONE CAPITAL MANAGEMENT LLC 469,405$17,715,3455.59%
Soditic Asset Management LLP 186,920$7,054,3615.43%
JONES ROAD CAPITAL MANAGEMENT, L.P. 131,000$4,943,9404.32%
Camber Capital Management LP 3,000,000$113,2203.73%
Carmignac Gestion 4,848,773$182,991,7183.36%
SHAPIRO CAPITAL MANAGEMENT LLC 3,028,799$114,306,8743.33%
Hillman Capital Management, Inc. 219,248$8,274,4203.19%
Cincinnati Specialty Underwriters Insurance CO 201,500$7,604,6102.90%
Callodine Capital Management, LP 265,000$10,001,1002.79%
View complete list of BAXTER INTL INC shareholders